Can Psychedelics Help Mend Broken and Ailing Brains?
Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psychedelics as novel therapies to promote brain repair and recovery. The post Can Psychedelics Help Mend Broken and Ailing Brains? appeared first on Chemical Collective.
External link. We are not responsible for the content.
Read more βMore From Chemical Collective
Psychedelics in the Age of Eco-Anxiety
Eco-anxiety is a rising response to environmental crises that can be transformed into resilience and action through s...
Heartbreak is a Bad Trip
Oli Genn-Bash describes how the aftermath of a sudden breakup felt like a prolonged βbad tripβ, as well as the potent...
What Are We to Make of Cosmic Insights and Visions on Psychedelics?
Psychedelic mystical experiences can involve insights and visions with cosmic themes. David Blackbourn explores why t...
Latest News
Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols
What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West ...
Evaluating the Pros and Cons of State Psychedelic Task Forces
While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psych...
Scientists test if ketamine has antidepressant effects under anesthesia; France is the first to approve IV ketamine for severe suicidal crisis
Plus: New research on the role of trip sitters; Various state bills move to expand psychedelics research and access
The Life You Call βNormalβ Was Designed
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
Wait, Are We In a Simulation?
This DMT laser experiment suggests yes, but neuroscientists say probably not. [...] Read More... The post Wait, Are W...
A Practitioner Statement on the Responsible Development of Ibogaine in the United States β Open Letter
Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with ...